Zurueck zur Suche

Reporte zur Charge U7633AA

Verknuepft ueber VAERS_ID mit VAERSDATA, Vax und Symptoms

6Reporte angezeigt
0Todesfaelle
0Hospitalisiert
0Lebensbedrohlich
0Bleibende Schaeden
CA 2 IL 1 TX 1 PA 1

VAERS 2714836

SANOFI PASTEUR · MENINGOCOCCAL CONJUGATE (MENACTRA) · Charge U7633AA

moderat
Staat
CA
Alter
27,0
Geschlecht
M
Eingang
17.11.2023
Impfdatum
06.09.2023
Beginn
06.09.2023
Tage bis Beginn
0,0
Dosis
4
Route/Site
IM / RA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Injected limb mobility decreased Injection site pain Pain

Symptomtext

At time of vaccine administration, "very painful" R deltoid IM pain with decreased R arm range of motion x 3-7 days. Since then, pain has improved but is still present - most notably while washing hair (arm in extended, adducted, externally rotated position)

Weitere VAERSDATA-Felder
Praegender Schweregrund
Injected limb mobility decreased
Hospital-Tage
-
Labordaten
None performed
Aktuelle Erkrankungen
None reported
Vorgeschichte
None
Andere Medikamente
None
Allergien
NKDA
Vorherige Impfungen
-

VAERS 2716656

SANOFI PASTEUR · MENINGOCOCCAL CONJUGATE (MENQUADFI) · Charge U7633AA

mild
Staat
-
Alter
16,0
Geschlecht
F
Eingang
22.11.2023
Impfdatum
21.11.2023
Beginn
21.11.2023
Tage bis Beginn
0,0
Dosis
2
Route/Site
IM / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Injection site erythema Injection site warmth

Symptomtext

Pt presents left arm with generalized redness at the site of the injection and is warm to the touch.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Injection site erythema
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2678831

SANOFI PASTEUR · MENINGOCOCCAL CONJUGATE (MENQUADFI) · Charge U7633AA

mild
Staat
CA
Alter
16,0
Geschlecht
M
Eingang
02.09.2023
Impfdatum
01.09.2023
Beginn
01.09.2023
Tage bis Beginn
0,0
Dosis
2
Route/Site
IM / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: ja Erholt: nein
Gait disturbance Pain Pain in extremity

Symptomtext

Patient reports 2 hours after receiving vaccine began to have pain behind legs calf area. Pain radiates from calf to ankle. Difficulty walking Left leg pain 8/10, right leg 6/10

Weitere VAERSDATA-Felder
Praegender Schweregrund
Pain
Hospital-Tage
-
Labordaten
09/02/2023 patient was advised by Dr. to go to ER for further evaluation
Aktuelle Erkrankungen
Positive for COVID 08/01/2023
Vorgeschichte
-
Andere Medikamente
-
Allergien
NKA
Vorherige Impfungen
-

VAERS 2661102

SANOFI PASTEUR · MENINGOCOCCAL CONJUGATE (MENQUADFI) · Charge U7633AA

mild
Staat
IL
Alter
10,0
Geschlecht
F
Eingang
26.07.2023
Impfdatum
17.07.2023
Beginn
17.07.2023
Tage bis Beginn
0,0
Dosis
1
Route/Site
IM / LL
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja
Hyperhidrosis Nausea

Symptomtext

After receiving the vaccine, pt stood up and felt nauseous + sweaty. She was laid down, ice to back of neck, legs raised, given a popcicle + felt better. She did not faint. She was feeling well when she left

Weitere VAERSDATA-Felder
Praegender Schweregrund
Nausea
Hospital-Tage
-
Labordaten
None
Aktuelle Erkrankungen
Allergic reaction at a camp
Vorgeschichte
Anxiety + Autism
Andere Medikamente
buspirone 10mg, methylphenidate 10mg
Allergien
Egg, dog dander
Vorherige Impfungen
4 month Dtap/Hib/IPV, Rotavirus 11/27/2012 p vaccine she passed out, slept for 4 hours lost some vocal skills, but then returned

VAERS 2721441

SANOFI PASTEUR · MENINGOCOCCAL CONJUGATE (MENQUADFI) · Charge U7633AA

gering
Staat
TX
Alter
77,0
Geschlecht
F
Eingang
06.12.2023
Impfdatum
13.07.2023
Beginn
13.07.2023
Tage bis Beginn
0,0
Dosis
UNK
Route/Site
- / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: unbekannt
Unevaluable event

Symptomtext

MenQuadfi dose was supposed to be administered on 7/13. Pt was never administered this dose and will need to be rescheduled

Weitere VAERSDATA-Felder
Praegender Schweregrund
Unevaluable event
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2618708

UNKNOWN MANUFACTURER · MENINGOCOCCAL (NO BRAND NAME) · Charge U7633AA

gering
Staat
PA
Alter
-
Geschlecht
U
Eingang
21.04.2023
Impfdatum
-
Beginn
-
Tage bis Beginn
-
Dosis
3
Route/Site
OT / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
No adverse event Product storage error

Symptomtext

3 doses of menquadfi were administered to patients post-excursion with no reported adverse event; 3 doses of menquadfi were administered to patients post-excursion with no reported adverse event; Initial information received on 14-Apr-2023 regarding an unsolicited non-valid non-serious case received via other health professional. This case involves 3 doses of menquadfi were administered to unspecified patients post-excursion with vaccine MENINGOCOCCAL A-C-Y-W135 (T CONJ) VACCINE [Menquadfi] with no reported adverse event. The patient's past medical history, medical treatment(s), concomitant(s) and family history were not provided. On an unknown date, the patient received suspect MENINGOCOCCAL A-C-Y-W135 (T CONJ) VACCINE (formulation, strength: unknown) at dose of 3 DF (Dosage Formulation) at dose number 3 (lot U7633AA, Expiry date: 25-Apr-2025) via unknown route in unknown administration site for prophylactic vaccination (immunization). On an unknown date the patient diagnosed with a non-serious 3 doses of menquadfi were administered to patients post-excursion with no reported adverse event (poor quality product administered) (product storage error) (same day latency) following the administration of meningococcal a-c-y-w135 (t conj) vaccine. Action taken was not applicable. At time of reporting, the outcome was Unknown. This suspected adverse reaction report is submitted and classified as a medication error solely and exclusively to ensure the marketing authorization holder's compliance with the requirements set out in the Directive 2001/83/EC and Module VI of the Good Pharmacovigilance Practices. The classification as a medical error is in no way intended, nor should it be interpreted or construed as an allegation or claim made by the marketing authorization holder that any third party has contributed to or is to be held liable for the occurrence of this medication error.

Weitere VAERSDATA-Felder
Praegender Schweregrund
No adverse event
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-